Andraž Perhavec

641 total citations
36 papers, 295 citations indexed

About

Andraž Perhavec is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Andraž Perhavec has authored 36 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cancer Research, 15 papers in Pathology and Forensic Medicine and 12 papers in Oncology. Recurrent topics in Andraž Perhavec's work include Breast Cancer Treatment Studies (17 papers), Breast Lesions and Carcinomas (15 papers) and Breast Implant and Reconstruction (10 papers). Andraž Perhavec is often cited by papers focused on Breast Cancer Treatment Studies (17 papers), Breast Lesions and Carcinomas (15 papers) and Breast Implant and Reconstruction (10 papers). Andraž Perhavec collaborates with scholars based in Slovenia, Hungary and Finland. Andraž Perhavec's co-authors include Janez Žgajnar, Nikola Bešič, Barbara Gazić, Marko Hočevar, Srdjan Novaković, Maja Pohar Perme, Ivica Ratoša, Snjez̆ana Frković‐Grazio, Päivi Heikkilä and Maja Podkrajšek and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Andraž Perhavec

30 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andraž Perhavec Slovenia 11 174 118 96 95 55 36 295
Siún Walsh Ireland 11 170 1.0× 137 1.2× 120 1.3× 156 1.6× 56 1.0× 26 454
Takefumi Yoshida Japan 11 97 0.6× 70 0.6× 212 2.2× 124 1.3× 58 1.1× 38 394
Daniel Herr Germany 9 146 0.8× 58 0.5× 134 1.4× 43 0.5× 22 0.4× 14 330
Marion Kuper‐Hommel New Zealand 12 176 1.0× 181 1.5× 195 2.0× 44 0.5× 63 1.1× 34 406
Amar Mahgoub United States 9 91 0.5× 56 0.5× 88 0.9× 158 1.7× 62 1.1× 18 401
Paul van Beest Netherlands 6 187 1.1× 70 0.6× 173 1.8× 99 1.0× 37 0.7× 8 395
Zeming Xie China 10 231 1.3× 84 0.7× 104 1.1× 66 0.7× 54 1.0× 20 343
Leo A. Niemeier United States 6 215 1.2× 95 0.8× 240 2.5× 97 1.0× 109 2.0× 8 526
Brian Rini United States 8 80 0.5× 29 0.2× 70 0.7× 65 0.7× 88 1.6× 14 246
Hesham M. Hassabo United States 8 113 0.6× 74 0.6× 159 1.7× 70 0.7× 56 1.0× 17 401

Countries citing papers authored by Andraž Perhavec

Since Specialization
Citations

This map shows the geographic impact of Andraž Perhavec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andraž Perhavec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andraž Perhavec more than expected).

Fields of papers citing papers by Andraž Perhavec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andraž Perhavec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andraž Perhavec. The network helps show where Andraž Perhavec may publish in the future.

Co-authorship network of co-authors of Andraž Perhavec

This figure shows the co-authorship network connecting the top 25 collaborators of Andraž Perhavec. A scholar is included among the top collaborators of Andraž Perhavec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andraž Perhavec. Andraž Perhavec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Perhavec, Andraž, et al.. (2024). COST-FACIT Analysis of Cancer Patients Treated with Radiotherapy in a Publicly Funded Healthcare System in One Country. International Journal of Radiation Oncology*Biology*Physics. 120(2). e424–e425.
3.
Gašljević, Gorana, et al.. (2023). Axillary ultrasound for predicting response to neoadjuvant treatment in breast cancer patients—a single institution experience. World Journal of Surgical Oncology. 21(1). 292–292. 3 indexed citations
4.
Gašljević, Gorana, et al.. (2023). Absence of post-treatment changes in sentinel lymph nodes does not translate into increased regional recurrence rate in initially node-positive breast cancer patients. Breast Cancer Research and Treatment. 202(3). 443–450. 1 indexed citations
5.
6.
Borštnar, Simona, et al.. (2022). Intraoperative Touch Imprint Cytology in Breast Cancer Patients After Neoadjuvant Chemotherapy. Clinical Breast Cancer. 22(4). e597–e603. 3 indexed citations
7.
Žgajnar, Janez, et al.. (2021). Trends and timing of risk-reducing mastectomy uptake in unaffected BRCA1 and BRCA2 carriers in Slovenia. European Journal of Surgical Oncology. 47(8). 1900–1906. 5 indexed citations
8.
Perhavec, Andraž, et al.. (2020). Primary localized retroperitoneal sarcomas: report from Slovenian sarcoma referral center. World Journal of Surgical Oncology. 18(1). 6 indexed citations
9.
Perhavec, Andraž, Salvatore Provenzano, Marco Baia, et al.. (2020). Inoperable Primary Retroperitoneal Sarcomas: Clinical Characteristics and Reasons Against Resection at a Single Referral Institution. Annals of Surgical Oncology. 28(2). 1151–1157. 14 indexed citations
10.
Perić, Barbara, et al.. (2020). Completely resected stage III melanoma controversy - 15 years of national tertiary centre experience. Radiology and Oncology. 55(1). 50–56. 1 indexed citations
11.
Novaković, Srdjan, Vida Stegel, Barbara Gazić, et al.. (2020). The prevalence of occult ovarian cancer in the series of 155 consequently operated high risk asymptomatic patients – Slovenian population based study. Radiology and Oncology. 54(2). 180–186. 3 indexed citations
12.
13.
Borštnar, Simona, Ana Blatnik, Andraž Perhavec, et al.. (2019). Smernice diagnostike in zdravljenja raka dojk. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Perhavec, Andraž, et al.. (2019). Is preoperative ultrasound of the axilla necessary in screen-detected breast cancer?. European Journal of Surgical Oncology. 46(1). 85–88. 4 indexed citations
15.
Meretoja, Tuomo J, Päivi Heikkilä, Aaron S. Mansfield, et al.. (2014). A Predictive Tool to Estimate the Risk of Axillary Metastases in Breast Cancer Patients with Negative Axillary Ultrasound. Annals of Surgical Oncology. 21(7). 2229–2236. 22 indexed citations
16.
Cserni, Gábor, Rita Bori, Róbert Maráz, et al.. (2012). Multi-Institutional Comparison of Non-sentinel Lymph Node Predictive Tools in Breast Cancer Patients with High Predicted Risk of Further Axillary Metastasis. Pathology & Oncology Research. 19(1). 95–101. 7 indexed citations
17.
Perhavec, Andraž, et al.. (2011). Preoperative serum thyroglobulin concentration is an independent predictive factor of malignancy in follicular neoplasms of the thyroid gland. Journal of Surgical Oncology. 105(4). 351–356. 40 indexed citations
18.
Cserni, Gábor, Gábor Boross, Róbert Maráz, et al.. (2011). Multicentre validation of different predictive tools of non-sentinel lymph node involvement in breast cancer. Surgical Oncology. 21(2). 59–65. 22 indexed citations
19.
Perhavec, Andraž, Maja Pohar Perme, Marko Hočevar, Nikola Bešič, & Janez Žgajnar. (2009). Ljubljana nomograms for predicting the likelihood of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node. Breast Cancer Research and Treatment. 119(2). 357–366. 20 indexed citations
20.
Perhavec, Andraž, Nikola Bešič, Marko Hočevar, & Janez Žgajnar. (2008). Touch Imprint Cytology of the Sentinel Lymph Nodes Might Not Be Indicated in Early Breast Cancer Patients with Ultrasonically Uninvolved Axillary Lymph Nodes. Annals of Surgical Oncology. 15(8). 2257–2262. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Siún Walsh Breakdown of academic impact, for papers by Takefumi Yoshida Breakdown of academic impact, for papers by Daniel Herr Breakdown of academic impact, for papers by Marion Kuper‐Hommel Breakdown of academic impact, for papers by Amar Mahgoub Breakdown of academic impact, for papers by Paul van Beest Breakdown of academic impact, for papers by Zeming Xie Breakdown of academic impact, for papers by Leo A. Niemeier Breakdown of academic impact, for papers by Brian Rini Breakdown of academic impact, for papers by Hesham M. Hassabo
Rankless by CCL
2026